Clinical trial NCT01597882: Improving Monitoring of Patients Receiving Case Management
Official title: Improved Targeting of Admission Avoidance Interventions in Older People With Long-term Conditions:An Observational,Longitudinal Study Exploring the Feasibility of Measures of Strength as a Monitoring Aid in Patients Receiving Case Management
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Multiple Conditions
Coronary Heart Disease
Diabetes
Hypertension
Chronic Obstructive Pulmonary Disease
Keywords: case management
long term conditions
aged sixty five and over
Lead sponsor: University of Southampton
Sponsor class: OTHER
First posted: 2012-05-14
Enrollment: 114
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients receiving cmmunity health case management.

Brief summary: The UK population is ageing and the likelihood of having a long term health condition increases with age. Three out of every five people over 60 in the UK have a long term condition. Ageing and having a long term condition increases the chance of having difficulty being independent and carrying out day to day activities. In recent years the NHS has made a greater effort to prevent these difficulties in patients with long term conditions.

One approach to help patients with long term conditions is case management, where by (usually) a community matron visits patients at home, looking for early warning signs of any worsening of their condition and arranging care and treatment. But the current way this is done varies across the country and hospital admissions are still rising. In order to give the right care at the right time, effective monitoring is needed to help the community matron detect and act on changes in the patient's condition.

Loss of muscle strength in old age is linked to a poor health, but it is not known whether simple measures of muscle strength could be used to detect and predict declines in health in the short to medium term to help maintain independence and prevent an accident or hospital admission.

The aim of this study is to look at whether monitoring muscle strength in case managed patients is practical, acceptable and useful in detecting when a patient's condition worsens. Each patient will be visited by the researcher in their home twice in the first week, then once every two weeks, for another 5 weeks, to carry out three simple measures of grip and respiratory strength, and complete questionnaires about their health and ability to carry out day to day activities. Each visit will last about 20 to 30 minutes. A small group of clinicians will be asked about their views of the strength measures. Database analysis will allow descriptive data on the patient group to be gathered and analysed.


Eligibility criteria: Inclusion Criteria:

* Patients aged 65 years or over receiving health case management in the community.

Exclusion Criteria:

1. Enrolled in any other research study
2. Preclude consent:

   * Significant cognitive impairment resulting in lack of capacity to consent. b. Unable to communicate without significant aids e.g. Non-English speaking.
3. Preclude participation/ collection of data

   * Significant emotional distress or psychotic illness active within the last 6 months.
   * Receiving end of life care.
   * Current illness that would preclude data collection.
   * Upper limb pathology that would limit participation e.g. bone fracture within the previous 6 months.
   * Identified as high risk patients with regards to lone working safety by their case manager.

Primary outcomes:
measure: Grip strength
timeFrame: 13 weeks
Secondary outcomes:
measure: Peak expiratory flow
timeFrame: 13 weeks
measure: Peak inspiratory flow
timeFrame: 13 weeks
measure: Sickness behaviour scale
timeFrame: 13 weeks
Other outcomes:
Locations:
city: Portsmouth
country: United Kingdom
facility: Solent NHS Trust
city: Southampton
country: United Kingdom
facility: Southern Health NHS Foundation Trust
Study officials:
affiliation: University of Southampton
name: Nicola Barnes, MPharm
role: PRINCIPAL_INVESTIGATOR
References: